PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization
/PRNewswire/ -- PhaseV a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has...
Source: prnewswire.com